5ht2b_human
NAME
4IB4
ORGANISM
Human (Homo sapiens)
PROTEIN NAME
5ht2b_human
SOURCE
SWISSPROT
SEQUENCE
Perspective:
Wild-type
Construct
|
|
|
|
|
|
|
|
|
|
N-term | |||||||||
M
|
A
|
L
|
S
|
Y
|
R
|
V
|
S
|
E
|
L
|
10 |
|
|
|
|
|
|
|
|
|
|
Q
|
S
|
T
|
I
|
P
|
E
|
H
|
I
|
L
|
Q
|
20 |
|
|
|
|
|
|
|
|
|
|
S
|
T
|
F
|
V
|
H
|
V
|
I
|
S
|
S
|
N
|
30 |
|
|
|
|
|
|||||
W
|
S
|
G
|
L
|
Q
|
T
|
E
|
S
|
I
|
P
|
40 |
E
|
E
|
M
|
K
|
Q
|
I
|
V
|
E
|
E
|
Q
|
50 |
TM1 | |||||||||
G
|
N
|
K
|
L
|
H
|
W
|
A
|
A
|
L
|
L
|
60 |
I
|
L
|
M
|
V
|
I
|
I
|
P
|
T
|
I
|
G
|
70 |
G
|
N
|
T
|
L
|
V
|
I
|
L
|
A
|
V
|
S
|
80 |
ICL1 | TM2 | ||||||||
L
|
E
|
K
|
K
|
L
|
Q
|
Y
|
A
|
T
|
N
|
90 |
Y
|
F
|
L
|
M
|
S
|
L
|
A
|
V
|
A
|
D
|
100 |
L
|
L
|
V
|
G
|
L
|
F
|
V
|
M
|
P
|
I
|
110 |
A
|
L
|
L
|
T
|
I
|
M
|
F
|
E
|
A
|
M
|
120 |
ECL1 | TM3 | ||||||||
W
|
P
|
L
|
P
|
L
|
V
|
L
|
C
|
P
|
A
|
130 |
W
|
L
|
F
|
L
|
D
|
V
|
L
|
F
|
S
|
T
|
140 |
|
|||||||||
A
|
S
|
I
|
M
|
H
|
L
|
C
|
A
|
I
|
S
|
150 |
V
|
D
|
R
|
Y
|
I
|
A
|
I
|
K
|
K
|
P
|
160 |
ICL2 | TM4 | ||||||||
I
|
Q
|
A
|
N
|
Q
|
Y
|
N
|
S
|
R
|
A
|
170 |
T
|
A
|
F
|
I
|
K
|
I
|
T
|
V
|
V
|
W
|
180 |
L
|
I
|
S
|
I
|
G
|
I
|
A
|
I
|
P
|
V
|
190 |
ECL2 | |||||||||
P
|
I
|
K
|
G
|
I
|
E
|
T
|
D
|
V
|
D
|
200 |
N
|
P
|
N
|
N
|
I
|
T
|
C
|
V
|
L
|
T
|
210 |
TM5 | |||||||||
K
|
E
|
R
|
F
|
G
|
D
|
F
|
M
|
L
|
F
|
220 |
G
|
S
|
L
|
A
|
A
|
F
|
F
|
T
|
P
|
L
|
230 |
A
|
I
|
M
|
I
|
V
|
T
|
Y
|
F
|
L
|
T
|
240 |
|
|
||||||||
I
|
H
|
A
|
L
|
Q
|
K
|
K
|
A
|
Y
|
L
|
250 |
|
|
|
|
|
|
|
|
|
|
ICL3 | |||||||||
V
|
K
|
N
|
K
|
P
|
P
|
Q
|
R
|
L
|
T
|
260 |
|
|
|
|
|
|
|
|
|
|
W
|
L
|
T
|
V
|
S
|
T
|
V
|
F
|
Q
|
R
|
270 |
|
|
|
|
|
|
|
|
|
|
D
|
E
|
T
|
P
|
C
|
S
|
S
|
P
|
E
|
K
|
280 |
|
|
|
|
|
|
|
|
|
|
V
|
A
|
M
|
L
|
D
|
G
|
S
|
R
|
K
|
D
|
290 |
|
|
|
|
|
|
|
|
|
|
K
|
A
|
L
|
P
|
N
|
S
|
G
|
D
|
E
|
T
|
300 |
|
|
|
|
|
|
|
|
|
|
L
|
M
|
R
|
R
|
T
|
S
|
T
|
I
|
G
|
K
|
310 |
|
|
|
|||||||
TM6 | |||||||||
K
|
S
|
V
|
Q
|
T
|
I
|
S
|
N
|
E
|
Q
|
320 |
R
|
A
|
S
|
K
|
V
|
L
|
G
|
I
|
V
|
F
|
330 |
F
|
L
|
F
|
L
|
L
|
M
|
W
|
C
|
P
|
F
|
340 |
F
|
I
|
T
|
N
|
I
|
T
|
L
|
V
|
L
|
C
|
350 |
ECL3 | TM7 | ||||||||
D
|
S
|
C
|
N
|
Q
|
T
|
T
|
L
|
Q
|
M
|
360 |
L
|
L
|
E
|
I
|
F
|
V
|
W
|
I
|
G
|
Y
|
370 |
V
|
S
|
S
|
G
|
V
|
N
|
P
|
L
|
V
|
Y
|
380 |
H8 | |||||||||
T
|
L
|
F
|
N
|
K
|
T
|
F
|
R
|
D
|
A
|
390 |
F
|
G
|
R
|
Y
|
I
|
T
|
C
|
N
|
Y
|
R
|
400 |
|
|
|
|
|
|||||
C-term | |||||||||
A
|
T
|
K
|
S
|
V
|
K
|
T
|
L
|
R
|
K
|
410 |
|
|
|
|
|
|
|
|
|
|
R
|
S
|
S
|
K
|
I
|
Y
|
F
|
R
|
N
|
P
|
420 |
|
|
|
|
|
|
|
|
|
|
M
|
A
|
E
|
N
|
S
|
K
|
F
|
F
|
K
|
K
|
430 |
|
|
|
|
|
|
|
|
|
|
H
|
G
|
I
|
R
|
N
|
G
|
I
|
N
|
P
|
A
|
440 |
|
|
|
|
|
|
|
|
|
|
M
|
Y
|
Q
|
S
|
P
|
M
|
R
|
L
|
R
|
S
|
450 |
|
|
|
|
|
|
|
|
|
|
S
|
T
|
I
|
Q
|
S
|
S
|
S
|
I
|
I
|
L
|
460 |
|
|
|
|
|
|
|
|
|
|
L
|
D
|
T
|
L
|
L
|
L
|
T
|
E
|
N
|
E
|
470 |
|
|
|
|
|
|
|
|
|
|
G
|
D
|
K
|
T
|
E
|
E
|
Q
|
V
|
S
|
Y
|
480 |
|
V
|
|
|
|
|
|
|
|
|
|
|
|
hemagglutin | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FLAG | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
N-term | |||||||||
|
T
|
E
|
S
|
I
|
P
|
E
|
E
|
M
|
K
|
44 |
Q
|
I
|
V
|
E
|
E
|
Q
|
G
|
N
|
K
|
L
|
54 |
TM1 | |||||||||
H
|
W
|
A
|
A
|
L
|
L
|
I
|
L
|
M
|
V
|
64 |
I
|
I
|
P
|
T
|
I
|
G
|
G
|
N
|
T
|
L
|
74 |
V
|
I
|
L
|
A
|
V
|
S
|
L
|
E
|
K
|
K
|
84 |
ICL1 | TM2 | ||||||||
L
|
Q
|
Y
|
A
|
T
|
N
|
Y
|
F
|
L
|
M
|
94 |
S
|
L
|
A
|
V
|
A
|
D
|
L
|
L
|
V
|
G
|
104 |
L
|
F
|
V
|
M
|
P
|
I
|
A
|
L
|
L
|
T
|
114 |
ECL1 | |||||||||
I
|
M
|
F
|
E
|
A
|
M
|
W
|
P
|
L
|
P
|
124 |
TM3 | |||||||||
L
|
V
|
L
|
C
|
P
|
A
|
W
|
L
|
F
|
L
|
134 |
|
|||||||||
D
|
V
|
L
|
F
|
S
|
T
|
A
|
S
|
I
|
W
|
144 |
H
|
L
|
C
|
A
|
I
|
S
|
V
|
D
|
R
|
Y
|
154 |
ICL2 | |||||||||
I
|
A
|
I
|
K
|
K
|
P
|
I
|
Q
|
A
|
N
|
164 |
TM4 | |||||||||
Q
|
Y
|
N
|
S
|
R
|
A
|
T
|
A
|
F
|
I
|
174 |
K
|
I
|
T
|
V
|
V
|
W
|
L
|
I
|
S
|
I
|
184 |
G
|
I
|
A
|
I
|
P
|
V
|
P
|
I
|
K
|
G
|
194 |
ECL2 | |||||||||
I
|
E
|
T
|
D
|
V
|
D
|
N
|
P
|
N
|
N
|
204 |
I
|
T
|
C
|
V
|
L
|
T
|
K
|
E
|
R
|
F
|
214 |
TM5 | |||||||||
G
|
D
|
F
|
M
|
L
|
F
|
G
|
S
|
L
|
A
|
224 |
A
|
F
|
F
|
T
|
P
|
L
|
A
|
I
|
M
|
I
|
234 |
V
|
T
|
Y
|
F
|
L
|
T
|
I
|
H
|
A
|
L
|
244 |
|
||||
Q
|
K
|
K
|
A
|
|
|
|
|
|
|
|
|
|
|
|
|
BRIL (b562R | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
TM6 | |||||||
Q
|
T
|
I
|
S
|
N
|
E
|
Q
|
R
|
321 |
A
|
S
|
K
|
V
|
L
|
G
|
I
|
V
|
F
|
F
|
331 |
L
|
F
|
L
|
L
|
M
|
W
|
C
|
P
|
F
|
F
|
341 |
I
|
T
|
N
|
I
|
T
|
L
|
V
|
L
|
C
|
D
|
351 |
ECL3 | TM7 | ||||||||
S
|
C
|
N
|
Q
|
T
|
T
|
L
|
Q
|
M
|
L
|
361 |
L
|
E
|
I
|
F
|
V
|
W
|
I
|
G
|
Y
|
V
|
371 |
S
|
S
|
G
|
V
|
N
|
P
|
L
|
V
|
Y
|
T
|
381 |
H8 | |||||||||
L
|
F
|
N
|
K
|
T
|
F
|
R
|
D
|
A
|
F
|
391 |
C-term | |||||||||
G
|
R
|
Y
|
I
|
T
|
C
|
N
|
Y
|
R
|
A
|
401 |
|
||||
T
|
K
|
S
|
V
|
|
|
|
|
|
|
|
|
|
|
|
|
PreScission | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
His(10) | |||||||||
|
|
|
|
|
|
|
|
|
|
SCHEMATIC
Perspective:
Wild-type
Construct
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIAGRAMS
MUTATIONS
Position | Wild-type | Mutated |
---|---|---|
144 | | M | W |
DELETIONS
MODIFICATIONS
AUXILIARY PROTEINS
Protein_type: signal
Name: hemagglutinin
Sequence: None
Deletions:
Positions: N-term_0 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: tag
Name: FLAG
Sequence: None
Deletions:
Positions: N-term_1 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: fusion
Name: BRIL (b562RIL)
Sequence: None
Deletions:
Positions: Within Receptor_2 249:313
Presence in Crystal:YES
Remarks: None
Protein_type: prot_cleavage
Name: PreScission site (3C)
Sequence: None
Deletions:
Positions: C-term_3 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: tag
Name: His(10)
Sequence: None
Deletions:
Positions: C-term_4 None:None
Presence in Crystal:NO
Remarks: None
EXPRESSION
Expression method | Host cell type | Host cell | Remarks |
---|---|---|---|
Baculovirus | Sf9 | Insect | Bac-to-Bac |
SOLUBILIZATION
Solvent type | Item | Concentration |
---|---|---|
detergent | DDM | 1.0 %w/v |
additive | CHS | 0.2 %w/v |
Remarks:
PURIFICATION
Purification type | Description |
---|---|
Alkylation by Iodoacetamide | None |
Proteolysis by HRV 3C protease | None |
Remarks:None
CRYSTALLIZATION
METHOD: in meso/LCP
TYPE: lipidic cubic phase (LCP) (monoolein (9.9 MAG))
PROTEIN CONCENTRATION: 50 mg/ml
Temperature: 20°C
ph : 8.0-8.5
Remarks: The protein-LCP mixture contained 40% (w/w) proteinsolution, 54% (w/w) monoolein (Sigma) and 6% (w/w) cholesterol
Chemical lists
Type | Item | Concentration |
---|---|---|
LCP lipid additive | ||
lipid | Cholesterol | 6 %w/w |
Detergent | ||
DDM | 0.05 %w/v | |
Detergent additive | ||
CHS | 0.01 %w/v | |
Additive | ||
Glycerol | 10 %w/v | |
Additional | ||
unknown | Tris/HCl pH 8.0 | 100 mM |
unknown | PEG400 | 30 %v/v |
unknown | Magnesium Sulfate | 50-75 mM |